| Ulwazi Oluyisisekelo | |
| Igama lomkhiqizo | I-Amantanamine hydrochloride (Ibanga Lezemithi) |
| Inombolo ye-CAS. | 665-66-7 |
| Ukubukeka | I-White Fine Crystalline Powder |
| Ibanga | I-Pharma Grade |
| Ukuncibilika kwamanzi | Encibilikayo |
| Isitoreji | Gcina ngaphansi kuka +30°C. |
| I-Shelf Life | iminyaka engu-2 |
| Iphakheji | 25kg/Isigubhu |
Incazelo Yomkhiqizo
| Igama Lomkhiqizo: | I-Amantanamine hydrochloride |
| Omqondofana: | I-Amantanamine hydrochloride, i-1-Adamantylamine hydrochloride, i-1-Aminoadamantane hydrochloride; I-Hydrochloride (200 mg);1-AdaMantanaMine hydrochloride, 99+% 100GR;1-AdaMantanaMine hydrochloride, 99+% 25GR;1-AdaMantanaMine hydrochloride, 99+% 5GR;1-adamantane amine hydrochlorideminode1; IHydrochloride |
| I-CAS: | 665-66-7 |
| MF: | I-C10H18ClN |
| MW: | 187.71 |
| I-EINECS: | 211-560-2 |
| Izigaba zomkhiqizo: | I-Influenza Virus;API;I-Intermediates & Fine Chemicals;I-Dopamine receptor;SYMADINE;inhibitor;i-Adamanane derivatives;chiral;Adamntanes;Pharmaceuticals;API's;1;665-66-7 |
Ukusetshenziswa Kwezokwelapha
I-Amantanamine hydrochlorideisetshenziswa ekwelapheni i-prophylactic noma izimpawu zomkhuhlane A.
Ibuye isetshenziswe njenge-antiparkinsonian ejenti, ukwelapha ukusabela okweqile kwe-pyramidal, kanye ne-neuralgia yangemuva.
Iphinde isetshenziswe i-NMDA-receptor antagoinst.






